Trial · NCT00702273
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With an Ongoing Pregnancy (Cumulative Ongoing Pregnancy Rate) | 150 µg Corifollitropin Alfa | 47.2 | Percentage of participants | ||
| Percentage of Participants With an Ongoing Pregnancy (Cumulative Ongoing Pregnancy Rate) | 200 IU RecFSH | 44.9 | Percentage of participants | ||
| Percentage of Participants in Follow up Trial With a Miscarriage Per Clinical Pregnancy | 150 µg Corifollitropin Alfa | 8.2 | Percentage of participants | ||
| Percentage of Participants in Follow up Trial With a Miscarriage Per Clinical Pregnancy | 200 IU RecFSH | 17.6 | Percentage of participants | ||
| Percentage of Participants in Follow up Trial With a Miscarriage Per Vital Pregnancy | 150 µg Corifollitropin Alfa | 0 | Percentage of participants | ||
| Percentage of Participants in Follow up Trial With a Miscarriage Per Vital Pregnancy | 200 IU RecFSH | 0 | Percentage of participants | ||
| Percentage of Participants in Follow up Trial With an Ectopic Pregnancy | 150 µg Corifollitropin Alfa | 1.2 | Percentage of participants | ||
| Percentage of Participants in Follow up Trial With an Ectopic Pregnancy | 200 IU RecFSH | 0.6 | Percentage of participants | ||
| Percentage of Participants in Follow up Trial With a Clinical Pregnancy | 150 µg Corifollitropin Alfa | 43.5 | Percentage of participants | ||
| Percentage of Participants in Follow up Trial With a Clinical Pregnancy | 200 IU RecFSH | 38.6 | Percentage of participants | ||
| Percentage of Participants in Follow up Trial With a Vital Pregnancy | 150 µg Corifollitropin Alfa | 39.9 | Percentage of participants | ||
| Percentage of Participants in Follow up Trial With a Vital Pregnancy | 200 IU RecFSH | 31.8 | Percentage of participants | ||
| Percentage of Participants in Follow up Trial With an Ongoing Pregnancy | 150 µg Corifollitropin Alfa | 38.7 | Percentage of participants | ||
| Percentage of Participants in Follow up Trial With an Ongoing Pregnancy | 200 IU RecFSH | 30.7 | Percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00702273/results